Total Medical devices industry M&A deals worth $1bn were announced globally in May 2022, led by ConMed’s $255m acquisition of In2Bones Global, according to GlobalData’s deals database.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked a decrease of 32% over the previous month of $1.47bn and a drop of 86.6% when compared with the last 12-month average, which stood at $7.47bn.
Comparing M&A deals value in different regions of the globe, Asia-Pacific held the top position, with total announced deals in the period worth $554.65m. At the country level, the US topped the list in terms of deal value at $265m.
In terms of volumes, North America emerged as the top region for Medical devices industry M&A deals globally, followed by Europe and then Asia-Pacific.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThe top country in terms of M&A deals activity in May 2022 was the US with 16 deals, followed by the Sweden with three and Canada with three.
In 2022, as of May, Medical devices M&A deals worth $9.75bn were announced globally, marking an increase of 72.1% year on year.
Medical devices industry M&A deals in May 2022: Top deals
The top five M&A deals accounted for 82.2% of the overall value during May 2022.
The combined value of the top five Medical devices M&A deals stood at $825.74m, against the overall value of $1bn recorded for the month.
The top five Medical devices industry M&A deals of May 2022 tracked by GlobalData were:
1) ConMed $255m acquisition deal with In2Bones Global
2) The $227.93m acquisition of 57.5% stake in Allm by DeNA
3) Straumann $138.06m acquisition deal with SunshineSmile
4) The $108.2m acquisition of Zhejiang Longterm Medical Technology by Winner Medical Group
5) Winner Medical Group $96.54m acquisition deal for 65.55% stake with Hunan Pingan Medical Device Technology
